Bruker to acquire certain product lines of Varian

NewsGuard 100/100 Score

Varian, Inc. (Nasdaq GS: VARI) announced today that Bruker Corporation (Nasdaq: BRKR) and Agilent Technologies, Inc. (NYSE: A) have entered into a definitive asset purchase agreement pursuant to which Bruker will acquire certain product lines of Varian.  As previously announced, Agilent committed to divest those product lines in connection with obtaining regulatory approval for Agilent's pending acquisition of Varian.  

The product lines to be acquired by Bruker are:

  • Varian's inductively coupled plasma mass spectrometry (ICP-MS) instruments business;
  • Varian's laboratory gas chromatography (Lab GC) instruments business; and
  • Varian's gas chromatography triple-quadrupole mass spectrometry (GC-MS QQQ) instruments business.

Agilent and Bruker announced that their transaction is subject to customary closing conditions and regulatory approvals, and is expected to close shortly after Agilent completes its acquisition of Varian (which Agilent anticipates will occur by April 30, 2010, following regulatory approvals).

SOURCE Varian, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A high-protein diet and elevation in the amino acid leucine may contribute to buildup of plaque in arteries